Skip to main content

Table 3 Proportion of retention and attrition after ART initiation in the follow-up period by coinfection status and gender, in Addis Ababa, Ethiopia, (September 2011 to December 2018)

From: Retention on antiretroviral therapy in person with HIV and viral hepatitis coinfection in Ethiopia: a retrospective cohort study

Outcome Coinfection, (n = 132) Monoinfection, (n = 514)
Male Female Total Male Female Total
n (%), 95%: CI
Retention
at 12 months 62(77.50)
[66.8–85.4]
45(86.53)
[73.8–93.6]
107(81.06)
[73.3–86.9]
195(86.66)
[81.5–90.5]
251(87.15)
[82.7–90.5]
446(86.96)
[83.7–89.6]
Cumulative retention 80(61.25)
[49.9–71.4]
52(80.76)
[67.3–89.5]
132(68.93)
[60.4–76.3]
225(77.77)
[71.8–82.7]
289(82.29)
[77.4–86.3]
514(80.35)
[76.6–83.5]
LTFU
LTFU at 12 months 17.5
[10.5–27.6]
7.69
[2.8–19.3]
13.63
[8.7–20.7]
10.66
[7.2–15.4]
9.72
[6.7–13.7]
10.11
[7.7–13.0]
Cumulative LTFU 31.25c
[20.8–41.6]
13.46c
[3.8–23.0]
24.24d
[16.8–31.6]
19.55
[14.3–24.7]
14.58
[10.4–18.6]
16.73d
[13.4–19.9]
Death       
Death at 12 months 5.0
[1.8–12.8]
5.76
[1.8–16.97]
5.3e
[2.5–10.8]
2.66
[1.19–5.8]
3.12
[1.-6–5.9]
2.91e
[1.76–4.7]
A cumulative death 7.5
[3.3–15.9]
5.76
[1.8–16.9]
6.81
[3.5–12.6]
2.66
[1.1–5.8]
3.12
[1.6–5.9]
2.91
[1.7–4.7]
  1. HIV-Monoinfection: negative for both hepatitis B virus and hepatitis C viruses; HIV-Coinfection: hepatitis B virus or hepatitis C virus positive; LTFU loss to follow-up c Compared LTFU between male and female in co-infected group and there is a significant difference with a p-value < 0.0203 d compared LTFU in coinfected versus monoinfected and there is a significant difference with a p-value (0.0318). e Compared death in coinfected versus monoinfected and there is a significant statistical association